To evaluate the duration of labour (active phase of labour) in nulliparous women with gestations between 37 and 41 6/7 weeks when 20 mg of Hyoscine butylbromide was applied intravenously and compared with similar patients that received a placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
218
Nulliparous women with gestations at term receive 20 mg of Hyoscine butylbromide upon arrival in the Labor and Delivery Unit (4-5 cms).
Nulliparous women with gestations at term receive 20 mg of saline solution upon arrival in the Labor and Delivery Unit (4-5 cms).
Saint Thomas Maternity Hospital
Panama City, Panama
Duration of first stage of labor
Time measured from the moment the patient receive the allocated medication/placebo to complete dilation
Time frame: 24 hours
Rate of cervical dilation
Speed of cervical dilation (cms/hour) from the moment the patient receive the allocated medication/placebo to complete dilation
Time frame: 24 hours
Duration of labor
Time measured from the moment the patient receive the allocated medication/placebo to delivery
Time frame: 24 hours
Fetal and neonatal complications
Number of adverse events (fetal or neonatal)
Time frame: 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.